SPE2DP26F7450↗
Teva Pharmaceuticals USA, Inc. received this contract from Dla Troop Support, Defense Logistics Agency: $1.03M obligated so far for drugs and biologicals. Its period of performance ended 2026-07-21.
Key facts · data as of Oct 23, 2026
- Recipient
- Teva Pharmaceuticals USA, Inc.
- Awarding agency
- Defense Logistics Agency (Department of Defense)
- Contracting office
- Dla Troop Support (SPE2DP)
- Obligated to date
- $1.03M
- Potential value
- $1.03M
- Ends
- 2026-07-21
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award SPE2DP26F7450, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_SPE2DP26F7450_9700_SPE2DP20D0002_9700
Teva Pharmaceuticals USA, Inc.: all federal awards · Department of Defense: spending · Dla Troop Support: what it buys
8512238186!ADENOVIRUS TYPE 4 AND TYPE 7
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- Dla Troop Support (SPE2DP)
- Competition
- Not competed
- Pricing
- Firm fixed price
- How it was bought
- Single-award IDIQ · under SPE2DP20D0002
- Where the work is
- Morris, NJ · district NJ-11
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2026-07-14. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-07-14 | 0 | $1.03M | 8512238186!ADENOVIRUS TYPE 4 AND TYPE 7 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗